Searching map area
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
? TBD
scientific article published on 05 August 2020
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
James R Seibold
Shervin Assassi
Oliver Distler
Toby Maher
Subject
Interstitial lung disease
References
Wikidata